Stay updated on Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Sign up to get notified when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed; no other substantive changes to core content, pricing, or time-slot information are present.
    Difference
    0.2%
    Check dated 2025-09-14T09:48:53.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T07:36:59.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed medical terms related to leukemia and various compounds, while removing several location-related terms and some medical classifications.
    Difference
    4%
    Check dated 2025-08-31T00:59:56.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.16.11 to v2.16.12 and has removed older dates from May and June 2025, replacing them with new dates in August 2025.
    Difference
    0.6%
    Check dated 2025-08-16T19:07:07.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T15:05:55.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1.0%
    Check dated 2025-08-02T13:52:24.000Z thumbnail image

Stay in the know with updates to Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab/Ipilimumab ± Azacitidine in MDS Clinical Trial page.